National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2024-30313"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2024-30313"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2024-12-19"
last_updated: "2024-12-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2024-30313"
document_type: "notice"
publication_date: "2024-12-19"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "89 FR 103845"
fr_volume: 89
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, SEP-4: NCI Clinical and Translational Cancer Research, February 04, 2025, 10 a.m. to February 05, 2025, 7 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland, 20850 which was published in the *Federal Register* on  November 14, 2024, FR Doc 2024-26497, 89 FR 90021.

This notice is being amended to change the meeting end time on February 05, 2025, from 7 p.m. to 2 p.m. The meeting is now, February 04, 2025, 10 a.m. to February 05, 2025, 2 p.m. The meeting dates, format, and location will stay the same. The meeting is closed to the public.

Dated: December 16, 2024.

David W. Freeman,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.